Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2023 年第 1 季持倉
持倉截至 2023/3/31，2023/5/15 申報。只含多頭部位，變化是跟 2022 年第 4 季比股數。
- 持股檔數
- 63
- 較 2022 年第 4 季 +9
- 總值
- $2.60 億
- 較 2022 年第 4 季 +$4,203 萬 (+19.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| KDNYChinook Therapeutics, Inc. | COM | 976,021 | $2,259 萬 | 8.7% | +157,986+19.3% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 93,000 | $2,253 萬 | 8.7% | +23,000+32.9% | 加碼 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 150,000 | $1,610 萬 | 6.2% | +75,000+100.0% | 加碼 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 120,000 | $1,277 萬 | 4.9% | +120,000 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 622,249 | $1,036 萬 | 4.0% | +272,249+77.8% | 加碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,083,118 | $944.5 萬 | 3.6% | −60,413−5.3% | 減碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 380,000 | $926.8 萬 | 3.6% | +165,000+76.7% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 452,821 | $909.3 萬 | 3.5% | +140,323+44.9% | 加碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 260,008 | $871.0 萬 | 3.3% | +19,385+8.1% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 221,463 | $779.3 萬 | 3.0% | +133,862+152.8% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 113,224 | $767.0 萬 | 2.9% | −77,543−40.6% | 減碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $741.0 萬 | 2.8% | – | – | – |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $712.1 萬 | 2.7% | – | – | – |
| ATXSAstria Therapeutics, Inc. | COM | 529,369 | $704.1 萬 | 2.7% | +56,887+12.0% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 881,329 | $634.6 萬 | 2.4% | +307,651+53.6% | 加碼 | – |
| ACLXArcellx, Inc. | COMMON STOCK | 202,834 | $624.9 萬 | 2.4% | −37,309−15.5% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 320,000 | $530.6 萬 | 2.0% | +320,000 | 新進 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 135,863 | $511.4 萬 | 2.0% | −145,058−51.6% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 357,287 | $437.0 萬 | 1.7% | +88,540+32.9% | 加碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 751,796 | $430.8 萬 | 1.7% | +251,796+50.4% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 40,000 | $428.9 萬 | 1.6% | −30,997−43.7% | 減碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 60,000 | $416.5 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| SGENSeagen Inc. | COM | 20,000 | $404.9 萬 | 1.6% | +15,000+300.0% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 10,750 | $400.5 萬 | 1.5% | +5,750+115.0% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 90,000 | $322.1 萬 | 1.2% | +40,000+80.0% | 加碼 | 歷史 |
| ETNB89bio, Inc. | COM | 200,000 | $304.6 萬 | 1.2% | +200,000 | 新進 | 歷史 |
| Esperion Therapeutics Inc Ne29664WAB1 | NOTE 4.000%11/1 | – | $300.8 萬 | 1.2% | – | – | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 684,127 | $263.4 萬 | 1.0% | +223,799+48.6% | 加碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 30,244 | $249.7 萬 | 1.0% | −30,386−50.1% | 減碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 25,000 | $243.1 萬 | 0.9% | −55,000−68.8% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 62,223 | $233.2 萬 | 0.9% | +2,223+3.7% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 35,000 | $230.9 萬 | 0.9% | +35,000 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 95,000 | $228.2 萬 | 0.9% | +55,000+137.5% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 12,500 | $227.1 萬 | 0.9% | +12,500 | 新進 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 20,000 | $218.3 萬 | 0.8% | −25,000−55.6% | 減碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 247,891 | $191.4 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 50,000 | $179.9 萬 | 0.7% | −60,000−54.5% | 減碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 460,979 | $179.3 萬 | 0.7% | −200,285−30.3% | 減碼 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 208,292 | $163.7 萬 | 0.6% | +20,000+10.6% | 加碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,492,771 | $155.2 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 143,064 | $154.4 萬 | 0.6% | −50,000−25.9% | 減碼 | 歷史 |
| Intrexon Corp46122TAA0 | NOTE 3.500% 7/0 | – | $146.6 萬 | 0.6% | – | – | – |
| NRIXNurix Therapeutics, Inc. | COM | 150,000 | $133.2 萬 | 0.5% | +70,000+87.5% | 加碼 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 650,000 | $126.8 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NARIInari Medical, Inc. | Stock | 20,000 | $123.5 萬 | 0.5% | −70,000−77.8% | 減碼 | 歷史 |
| ADCTADC Therapeutics SA | SHS | 600,000 | $117.0 萬 | 0.4% | +600,000 | 新進 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 149,586 | $108.7 萬 | 0.4% | −153,632−50.7% | 減碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 62,500 | $97.9 萬 | 0.4% | +62,500 | 新進 | 歷史 |
| THRXTheseus Pharmaceuticals, Inc. | COM | 98,221 | $87.2 萬 | 0.3% | +98,221 | 新進 | 歷史 |
| BCABBioAtla, Inc. | COM | 325,000 | $87.1 萬 | 0.3% | +175,000+116.7% | 加碼 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM | 476,948 | $86.3 萬 | 0.3% | +476,948 | 新進 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 136,771 | $84.8 萬 | 0.3% | +26,780+24.3% | 加碼 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 199,382 | $78.6 萬 | 0.3% | +99,382+99.4% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 100,000 | $73.8 萬 | 0.3% | +100,000 | 新進 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 177,349 | $54.8 萬 | 0.2% | +177,349 | 新進 | 歷史 |
| NLS Pharmaceutics LtdH57830103 | SHS | 344,089 | $52.0 萬 | 0.2% | +344,089 | 新進 | – |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $41.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 306,950 | $30.0 萬 | 0.1% | +306,950 | 新進 | – |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $27.0 萬 | 0.1% | 00.0% | 不變 | – |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 37,000 | $6.84 萬 | <0.1% | +37,000 | 新進 | 歷史 |
| SCLXWScilex Holding Co | *W EXP 11/10/202 | 18,099 | $1.90 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $1.23 萬 | <0.1% | +75,000 | 新進 | – |
| SCLXScilex Holding Co | COM | 463 | $3,797 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（11 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | – | $1,842 萬 |
| BBIOBridgeBio Pharma, Inc. | COM | $646.3 萬 | – |
| MRNAModerna, Inc. | Stock | – | $537.5 萬 |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $347.1 萬 |
| VRDNViridian Therapeutics, Inc. | COM | – | $255.7 萬 |
| NVAXNovavax Inc | COM NEW | $240.3 萬 | – |
| VKTXViking Therapeutics, Inc. | COM | $156.3 萬 | – |
| ACRSAclaris Therapeutics, Inc. | COM | – | $104.4 萬 |
| ESPREsperion Therapeutics, Inc. | COM | $55.6 萬 | – |
| ETNB89bio, Inc. | COM | – | $55.1 萬 |
| CBIOCrescent Biopharma, Inc. | COM | $37.8 萬 | – |
2022 年第 4 季之後清倉（6 檔）
2022 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 4 季股數 | 2022 年第 4 季市值 | 2022 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| RCKTRocket Pharmaceuticals, Inc. | COM | 258,115 | $505.1 萬 | 2.3% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 100,000 | $254.5 萬 | 1.2% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 375,000 | $239.6 萬 | 1.1% | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 92,170 | $106.8 萬 | 0.5% | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 883,654 | $58.4 萬 | 0.3% | 歷史 |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $2,933 | <0.1% | – |